Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility

References

• Hallek M. Chronic lymphocytic leukemia: 2015 update on diagnosis, risk stratification, and treatment. Am J Hematol. 2015;90(5):446–460. doi:10.1002/ajh.23979
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804–815.
   PubMed Web of Science ®Google Scholar
• Eichhorst B, Dreyling M, Robak T, Montserrat E, Hallek M; ESMO Guidelines Working Group. Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):vi50–4.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer facts & figures 2020 Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Accessed March 8, 2021.
   Google Scholar
• Howlader N, Noone AM, Krapcho M, et al., eds. Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975-2017. Bethesda, MD: National Cancer Institute. Available from: https://seer.cancer.gov/csr/1975_2017/. Accessed March 8, 2021.
   Google Scholar
• Chiu BC, Hou N. Epidemiology and etiology of non-hodgkin lymphoma. Cancer Treat Res. 2015;165:1–25.
   PubMedGoogle Scholar
• Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017.
   Google Scholar
• Leukemia and Lymphoma Society Treatment for indolent NHL subtypes Available from: https://www.lls.org/lymphoma/non-hodgkin-lymphoma/treatment/treatment-for-indolent-nhl-subtypes. Accessed March 8, 2021.
   Google Scholar
• National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®). B-cell Lymphomas. Version 4.2020. 2020.
   Google Scholar
• Scarfo L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169–182.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Ghielmini M, Rule S, et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v83–v90.
   PubMed Web of Science ®Google Scholar
• Teva Pharmaceuticals USA, Inc. Treanda^® (Bendamustine Hydrochloride Injection and Bendamustine Hydrochloride for Injection) Prescribing Information. North Wales, PA.
   Google Scholar
• Eagle Pharmaceuticals, Inc. Belrapzo™ (bendamustine hydrochloride injection), for intravenous use, prescribing information. Woodcliff Lake, NJ 2020 Available from: https://belrapzo.com/. Accessed October 2020.
   Google Scholar
• Teva Pharmaceuticals USA, Inc. Bendeka^® (Bendamustine Hydrochloride Injection), for Intravenous Use, Prescribing Information. North Wales, PA; 2019.
   Google Scholar
• Food and Drug Administration. Guidance for Industry: Applications Covered by Section 505(b)(2). Draft Guidance October 1999 Available from: https://www.fda.gov/media/72419/download. Accessed March 8, 2021.
   Google Scholar
• Cheung EM, Edenfield WJ, Mattar B, et al. Safety and pharmacokinetics of bendamustine rapid-infusion formulation. J Clin Pharmacol. 2017;57(11):1400–1408.
   Web of Science ®Google Scholar
• Edenfield WJ, Mattar B, Anthony SP, Mutch P, Chanas B, Smith M, editors. Phase 1, open-label, randomized, bioequivalence study of 2 bendamustine hydrochloride formulations; a ready-to-dilute low-volume, rapid infusion solution and a lyophilized powder formulation. Blood. 2015;126(23):4857.
   Web of Science ®Google Scholar
• Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good Practice II Task Force. Value Health. 2014;17(1):5–14.
   PubMed Web of Science ®Google Scholar
• Yu S Infusion center insights: how do your chemo nurse staffing numbers compare? July 24, 2019. Published in Advisory Board: Oncology Rounds. Available from: https://www.advisory.com/research/oncology-roundtable/oncology-rounds/2016/03/infusion-center-insights-staffing. Accessed March 8, 2021.
   Google Scholar
• Bach S, editor. Scheduling and Patient Flow in an Outpatient Chemotherapy Infusion Center. Montreal, Canada: Institute of Industrial & Systems Engineers (ISERC);2014 June2. Presentation.
   Google Scholar
• Richardson D, Rouhana M, editors. Improving outpatient flow in a chemotherapy infusion center. Healthcare Systems Process Improvement Conference; 2016 February; Houston, TX. Presentation.
   Google Scholar
• United States Census Bureau. 2019 American Community Survey (ACS) annual estimates of the resident population (Table DP05) Available from: https://data.census.gov/cedsci. Accessed March 8, 2021.
   Google Scholar
• Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA. Real-world testing and treatment patterns in chronic lymphocytic leukemia: a SEER patterns of care analysis. Cancer. 2019;125(1):135–143.
   PubMed Web of Science ®Google Scholar
• Ammann EM, Shanafelt TD, Larson MC, et al. Time to second-line treatment and subsequent relative survival in older patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17(12):e11–e25.
   Web of Science ®Google Scholar
• Campo E, Cymbalista F, Ghia P, et al. TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics. Haematologica. 2018;103(12):1956–1968.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia. Version 2.2021. December 3, 2020.
   Google Scholar
• Emond B, Sundaram M, Romdhani H, Lefebvre P, Wang S, Mato A. Comparison of time to next treatment, health care resource utilization, and costs in patients with chronic lymphocytic leukemia initiated on front-line ibrutinib or chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019;19(12):763–75.e2.
   PubMed Web of Science ®Google Scholar
• Kabadi SM, Goyal RK, Nagar SP, Kaye JA, Davis KL. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States. Cancer Med. 2019;8(8):3803–3810.
   PubMed Web of Science ®Google Scholar
• Huang SJ, Gerrie AS, Young S, et al. Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada. Leuk Res. 2020;91:106335.
   PubMed Web of Science ®Google Scholar
• Batlevi CL, Sha F, Alperovich A, et al. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups. Blood Cancer J. 2020;10(7):74.
   PubMed Web of Science ®Google Scholar
• Morrison VA, Shou Y, Bell JA, et al. Treatment patterns and survival outcomes in patients with follicular lymphoma: a 2007 to 2015 Humedica database study. Clin Lymphoma Myeloma Leuk. 2019.
   Google Scholar
• Ren J, Asche CV, Shou Y, Galaznik A. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA. J Comp Eff Res. 2019.
   Web of Science ®Google Scholar
• Fowler NH, Chen G, Lim S, Manson S, Ma Q, Li FY. Treatment patterns and health care costs in commercially insured patients with follicular lymphoma. J Health Econ Outcomes Res. 2020;7(2):148–157.
   Google Scholar
• Sacco JJ, Botten J, Macbeth F, Bagust A, Clark P. The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PLoS One. 2010;5(1):e8933.
   PubMed Web of Science ®Google Scholar
• Wallington M, editor Variations in body surface area of patients receiving chemotherapy treatment in England. National Cancer Research Institute (Public Health England) Cancer Outcomes Conference (Poster #26); 2013 June; Brighton.
   Google Scholar
• Dhongde S. Multidimensional economic deprivation during the coronavirus pandemic: early evidence from the United States. PLoS One. 2020;15(12):e0244130.
   PubMed Web of Science ®Google Scholar
• United States Department of Labor - Bureau of Labor Statistics. Occupational employment and wages, 2019: 29–1141. Available from: https://www.bls.gov/oes/current/oes291141.htm. Accessed March 8, 2021.
   Google Scholar
• Schmier J, Ogden K, Nickman N, et al. Costs of providing infusion therapy for rheumatoid arthritis in a Hospital-based Infusion Center Setting. Clin Ther. 2017;39(8):1600–1617.
   PubMed Web of Science ®Google Scholar
• Gabriel S, Welstead J, Shockley S, Barr P. An in-depth interview study of oncology nurses and infusion pharmacists of bendamustine product attributes that drive relative product preferences. J Clin Oncol. 2017;35(suppl;abstract e19007).
   Google Scholar